CGEM SG&A Expense Growth

Cullinan Therapeutics Inc · SG&A Expense Growth

CGEM logo

CGEM SG&A Expense Growth

Latest reported1.00%
CGEM FY SG&A Growth (YoY) (0.00% → 1.00%)
High-resolution chart · PNG

CGEM sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cullinan Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
0.998%
26.3973%
5.7329%
37.8886%
70.2056%
212.3677%
9.5962%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.